Prostate drug may change surgery results, study hopes to find out
NCT ID NCT07417449
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looks at whether taking dutasteride for at least 6 months before HoLEP surgery for an enlarged prostate affects bleeding, operation time, and tissue removal. Researchers will compare 1,000 men who took the drug with those who did not. The goal is to help surgeons plan better based on medication history.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dutasteride
- What this could lead to
- If it works, this could help surgeons know whether long-term dutasteride use reduces bleeding or improves efficiency during HoLEP surgery.
- What could go wrong
- This is an observational study, not a controlled trial, so it can't prove cause and effect. Results may not apply to all patients or other prostate surgeries.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC HYPERPLASIA, BENIGN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ankara Bilkent City Hospital
RECRUITINGAnkara, Universiteler, 06800, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.